Delivering a synthetic microRNA mimic let-7b to activate TLR-7 and inhibit IL-10 production in breast cancer mouse model can effectively reprogram the function of TAMs/TIDCs, reverse the TME and inhibit tumor growth [114]. This evidence concerns the gene IL10 and neoplasm.